186 related articles for article (PubMed ID: 34729872)
1. Association between fetal vascular malperfusion and gestational diabetes.
Goto T; Sato Y; Kodama Y; Tomimori K; Sameshima H; Aman M; Maekawa K; Yamashita A; Asada Y
J Obstet Gynaecol Res; 2022 Jan; 48(1):80-86. PubMed ID: 34729872
[TBL] [Abstract][Full Text] [Related]
2. Macroscopic lesions of maternal and fetal vascular malperfusion in stillborn placentas: Diagnosis in the absence of microscopic histopathological examination.
Cersonsky TEK; Silver RM; Saade GR; Dudley DJ; Reddy UM; Pinar H
Placenta; 2023 Sep; 140():60-65. PubMed ID: 37536149
[TBL] [Abstract][Full Text] [Related]
3. Placental CD34 immunohistochemistry in fetal vascular malperfusion in stillbirth.
Stanek J; Drach A
J Obstet Gynaecol Res; 2022 Mar; 48(3):719-728. PubMed ID: 35092332
[TBL] [Abstract][Full Text] [Related]
4. Placenta in intrauterine fetal demise (IUFD): a comprehensive study from a tertiary care hospital.
Manocha A; Ravikumar G; Crasta J
J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3939-3947. PubMed ID: 29792056
[No Abstract] [Full Text] [Related]
5. The placental component and neonatal outcome in singleton vs. twin pregnancies complicated by gestational diabetes mellitus.
Weiner E; Barber E; Feldstein O; Schreiber L; Dekalo A; Mizrachi Y; Bar J; Kovo M
Placenta; 2018 Mar; 63():39-44. PubMed ID: 29486855
[TBL] [Abstract][Full Text] [Related]
6. The Placenta in Neonatal Encephalopathy: A Case-Control Study.
Vik T; Redline R; Nelson KB; Bjellmo S; Vogt C; Ng P; Strand KM; Nu TNT; Oskoui M
J Pediatr; 2018 Nov; 202():77-85.e3. PubMed ID: 30369428
[TBL] [Abstract][Full Text] [Related]
7. Temporal heterogeneity of placental segmental fetal vascular malperfusion: timing but not etiopathogenesis.
Stanek J
Virchows Arch; 2021 May; 478(5):905-914. PubMed ID: 32918597
[TBL] [Abstract][Full Text] [Related]
8. Segmental villous mineralization: A placental feature of fetal vascular malperfusion.
Stanek J
Placenta; 2019 Oct; 86():20-27. PubMed ID: 31358342
[TBL] [Abstract][Full Text] [Related]
9. Maternal and fetal vascular lesions of malperfusion in the placentas associated with fetal and neonatal death: results of a prospective observational study.
Kulkarni VG; Sunilkumar KB; Nagaraj TS; Uddin Z; Ahmed I; Hwang K; Goudar SS; Guruprasad G; Saleem S; Tikmani SS; Dhaded SM; Yogeshkumar S; Somannavar MS; McClure EM; Goldenberg RL
Am J Obstet Gynecol; 2021 Dec; 225(6):660.e1-660.e12. PubMed ID: 34111407
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of the Large Fetal Vessel Lesions in Placental Fetal Vascular Malperfusion.
Stanek J
Lab Invest; 2024 May; 104(7):102089. PubMed ID: 38810837
[TBL] [Abstract][Full Text] [Related]
11. Is there a difference in placental pathology in pregnancies complicated with gestational diabetes A2 versus gestational diabetes A1, versus one abnormal value, on 100 gr glucose tolerance test?
Nataly F; Hadas GH; Ohad G; Letizia S; Michal K
Placenta; 2022 Mar; 120():60-64. PubMed ID: 35217317
[TBL] [Abstract][Full Text] [Related]
12. CD34 immunostain increases sensitivity of the diagnosis of fetal vascular malperfusion in placentas from ex-utero intrapartum treatment.
Stanek J
J Perinat Med; 2021 Feb; 49(2):203-208. PubMed ID: 32903209
[TBL] [Abstract][Full Text] [Related]
13. Placental maternal vascular malperfusion and adverse pregnancy outcomes in gestational diabetes mellitus.
Scifres CM; Parks WT; Feghali M; Caritis SN; Catov JM
Placenta; 2017 Jan; 49():10-15. PubMed ID: 28012449
[TBL] [Abstract][Full Text] [Related]
14. CD34 immunostain increases the sensitivity of placental examination for distal fetal vascular malperfusion in liveborn infants.
Stanek J
Placenta; 2023 Sep; 140():117-124. PubMed ID: 37573725
[TBL] [Abstract][Full Text] [Related]
15. Fetal vascular malperfusion (FVM): diagnostic implications and clinical associations.
Ravikumar G; Mascarenhas D; Suman Rao PN; Crasta J
J Matern Fetal Neonatal Med; 2022 Dec; 35(23):4526-4533. PubMed ID: 33261528
[TBL] [Abstract][Full Text] [Related]
16. Altered Levels of Decidual Immune Cell Subsets in Fetal Growth Restriction, Stillbirth, and Placental Pathology.
Bezemer RE; Schoots MH; Timmer A; Scherjon SA; Erwich JJHM; van Goor H; Gordijn SJ; Prins JR
Front Immunol; 2020; 11():1898. PubMed ID: 32973787
[TBL] [Abstract][Full Text] [Related]
17. Distal villous lesions are clinically more relevant than proximal large muscular vessel lesions of placental fetal vascular malperfusion.
Stanek J
Histol Histopathol; 2022 Apr; 37(4):365-372. PubMed ID: 34939657
[TBL] [Abstract][Full Text] [Related]
18. Intrauterine Fetal Demise Associated with Vascular Malperfusion and Multiple Uterine Leiomyomata: A Report of Two Cases.
Cersonsky TEK; Lord M; Pinar H
Fetal Pediatr Pathol; 2023 Feb; 42(1):83-92. PubMed ID: 35243966
[TBL] [Abstract][Full Text] [Related]
19. The Association of Fetal Congenital Cardiac Defects and Placental Vascular Malperfusion.
Ozcan T; Kikano S; Plummer S; Strainic J; Ravishankar S
Pediatr Dev Pathol; 2021; 24(3):187-192. PubMed ID: 33491545
[TBL] [Abstract][Full Text] [Related]
20. Placental pathology in pregnancies with late fetal growth restriction and abnormal cerebroplacental ratio.
Shmueli A; Mor L; Blickstein O; Sela R; Weiner E; Gonen N; Schreiber L; Levy M
Placenta; 2023 Jul; 138():83-87. PubMed ID: 37224646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
